ARBS CORONA II, Canada

Registration Status: Completed

Objective: The purpose of this registry is to try to better understand COVID-19 and other new respiratory infections by collecting blood and clinical data. The clinical data will be used to investigate long-term effects of COVID-19 on the health of patients previously infected. The blood samples are collected to find markers associated with COVID-19, such as DNA/RNA and proteins and for other genetic testing.

Registered Biobank Name ARBS CORONA II
Biobank Leader Puneet Mann
Country Canada
Email for biobank inquiries pmann7@providencehealth.bc.ca
Principal Investigator Dr Jim Russell
User Type
  • Mono: A biobank that supports a specific research project, may have few staff members, a small-scale accrual scope with little to no initial intention of releasing or distributing biospecimens to secondary parties
  • Oligo: A biobank that supports several research groups or clinical trials, may or may not be designed to release biospecimens outside their collaborative group
  • Poly: A biobank that has generally a larger accrual scope, resources, and multiple users outside the biobank proper
Biospecimen Collected: